• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超重和肥胖对系统性红斑狼疮患者报告的健康相关生活质量的影响。

Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus.

机构信息

Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Rheumatology, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Rheumatology (Oxford). 2021 Mar 2;60(3):1260-1272. doi: 10.1093/rheumatology/keaa453.

DOI:10.1093/rheumatology/keaa453
PMID:32918459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7937019/
Abstract

OBJECTIVES

Associations between BMI and health-related quality of life (HRQoL) in SLE have been implied, but data are scarce. We determined the impact of overweight and obesity on HRQoL in a large SLE population.

METHODS

We pooled cross-sectional baseline data from the BLISS-52 (NCT00424476) and BLISS-76 (NCT00410384) trials (N = 1684). HRQoL was evaluated using the 36-item Short Form Health Survey (SF-36), Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue scale and the European Quality of Life 5-dimension questionnaire (EQ-5D). Comparisons between BMI groups were conducted using the Mann-Whitney U test and adjustments using linear regression. Clinical relevance was determined by minimal clinically important differences (MCIDs).

RESULTS

In total, 43.2% of the patients had BMI above normal and 17.4% were obese. Overweight and obese patients reported worse SF-36 physical component summary (PCS), physical functioning, role physical, bodily pain and FACIT-Fatigue scores than normal weight patients. Divergences were greater than corresponding MCIDs and more prominent with increasing BMI. Despite no clinically important difference in SF-36 mental component summary scores across BMI categories, patients experienced progressively diminished vitality and social functioning with increasing BMI. In linear regression analysis, BMI above normal and obesity were associated with worse PCS (standardized coefficient β = -0.10, P < 0.001 and β = -0.17, P < 0.001, respectively), FACIT-Fatigue (β = -0.11, P < 0.001 and β = -0.16, P < 0.001) and EQ-5D (β = -0.08, P = 0.001 and β = -0.12, P < 0.001) scores, independently of demographic and disease-related factors. The impact of BMI on the PCS and FACIT-Fatigue was more pronounced than that of SLE activity.

CONCLUSION

Patients with SLE and BMI above normal experienced clinically important HRQoL diminutions in physical aspects, fatigue and social functioning. A survey of potential causality underlying this association is warranted.

摘要

目的

已有研究表明,BMI 与 SLE 患者的健康相关生活质量(HRQoL)之间存在关联,但相关数据仍然有限。本研究旨在探究超重和肥胖对大型 SLE 患者 HRQoL 的影响。

方法

本研究对 BLISS-52(NCT00424476)和 BLISS-76(NCT00410384)两项临床试验的基线横断面数据进行了汇总分析(N=1684)。采用 36 项简明健康调查问卷(SF-36)、慢性病治疗功能评估-疲劳量表(FACIT-Fatigue)和欧洲五维健康量表(EQ-5D)评估 HRQoL。使用 Mann-Whitney U 检验比较 BMI 组间差异,并用线性回归进行调整。采用最小临床重要差异(MCID)来判断临床相关性。

结果

共 43.2%的患者 BMI 高于正常值,17.4%的患者为肥胖。与体重正常的患者相比,超重和肥胖患者的 SF-36 生理成分综合评分(PCS)、生理职能、躯体疼痛和 FACIT-Fatigue 疲劳评分更差。这种差异大于相应的 MCID,且随着 BMI 的增加而更加显著。尽管 BMI 类别之间的 SF-36 心理成分综合评分无明显的临床差异,但患者的活力和社会功能随着 BMI 的增加而逐渐下降。在线性回归分析中,BMI 高于正常值和肥胖与 PCS(标准化系数β=-0.10,P<0.001 和β=-0.17,P<0.001)、FACIT-Fatigue(β=-0.11,P<0.001 和β=-0.16,P<0.001)和 EQ-5D(β=-0.08,P=0.001 和β=-0.12,P<0.001)评分差独立相关,且不受人口统计学和疾病相关因素的影响。BMI 对 PCS 和 FACIT-Fatigue 的影响比 SLE 疾病活动度的影响更为显著。

结论

BMI 高于正常值的 SLE 患者在生理功能、疲劳和社会功能方面的 HRQoL 明显下降。有必要对这种关联的潜在因果关系进行调查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7937019/cf8716474899/keaa453f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7937019/60b4874af136/keaa453f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7937019/13cf463c4939/keaa453f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7937019/39531e912ed8/keaa453f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7937019/e74188d7e9ba/keaa453f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7937019/cf8716474899/keaa453f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7937019/60b4874af136/keaa453f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7937019/13cf463c4939/keaa453f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7937019/39531e912ed8/keaa453f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7937019/e74188d7e9ba/keaa453f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfb2/7937019/cf8716474899/keaa453f5.jpg

相似文献

1
Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus.超重和肥胖对系统性红斑狼疮患者报告的健康相关生活质量的影响。
Rheumatology (Oxford). 2021 Mar 2;60(3):1260-1272. doi: 10.1093/rheumatology/keaa453.
2
Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE.肥胖指数异常对系统性红斑狼疮患者 52 周治疗后健康相关生活质量不良结局的影响。
Rheumatology (Oxford). 2021 Sep 1;60(9):4205-4217. doi: 10.1093/rheumatology/keaa909.
3
Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.缓解和低疾病活动度对系统性红斑狼疮患者健康相关生活质量的影响。
Rheumatology (Oxford). 2022 Nov 28;61(12):4752-4762. doi: 10.1093/rheumatology/keac185.
4
SF-36v2 and FACIT-Fatigue quality of life improvements with organ-specific SELENA-SLEDAI response and belimumab treatment in patients with systemic lupus erythematosus.SF-36v2 和 FACIT-Fatigue 生活质量在系统性红斑狼疮患者的器官特异性 SELENA-SLEDAI 反应和贝利尤单抗治疗中的改善。
Lupus Sci Med. 2024 May 8;11(1):e001118. doi: 10.1136/lupus-2023-001118.
5
Use of Antimalarial Agents is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus.抗疟药的使用与系统性红斑狼疮患者良好的身体功能相关。
J Clin Med. 2020 Jun 10;9(6):1813. doi: 10.3390/jcm9061813.
6
Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials.在随机对照 BLISS 试验中,B 淋巴细胞刺激物特异性抑制剂贝利尤单抗可改善自身抗体阳性系统性红斑狼疮患者的健康相关生活质量。
Ann Rheum Dis. 2014 May;73(5):838-44. doi: 10.1136/annrheumdis-2012-202865. Epub 2013 Mar 22.
7
Patients with NPSLE experience poorer HRQoL and more fatigue than SLE patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity.神经精神性狼疮患者的 HRQoL 较无神经精神性系统性红斑狼疮且无脑神经病变活动的系统性红斑狼疮患者更差,无论是否存在神经精神病变活动。
Rheumatology (Oxford). 2024 Sep 1;63(9):2494-2502. doi: 10.1093/rheumatology/keae216.
8
Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76).系统性红斑狼疮患者FACIT疲劳量表的心理测量学特性:三项3期随机、双盲、平行组对照研究(BLISS-SC、BLISS-52、BLISS-76)的汇总分析
J Patient Rep Outcomes. 2021 Apr 8;5(1):33. doi: 10.1186/s41687-021-00298-x.
9
Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus.尽管系统性红斑狼疮患者对治疗有充分的临床反应,但仍出现与健康相关的生活质量不良结局。
Front Med (Lausanne). 2021 Apr 16;8:651249. doi: 10.3389/fmed.2021.651249. eCollection 2021.
10
The Impact of Belimumab and Rituximab on Health-Related Quality of Life in Patients With Systemic Lupus Erythematosus.贝利尤单抗和利妥昔单抗对系统性红斑狼疮患者健康相关生活质量的影响。
Arthritis Care Res (Hoboken). 2019 Jun;71(6):811-821. doi: 10.1002/acr.23718.

引用本文的文献

1
Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study.绝经激素治疗与系统性红斑狼疮和系统性硬化症的风险:一项基于人群的巢式病例对照研究。
Rheumatology (Oxford). 2025 Jun 1;64(6):3563-3570. doi: 10.1093/rheumatology/keaf004.
2
Patient-reported outcome measures for lupus nephritis: content validity of LupusQoL and FACIT-Fatigue.狼疮肾炎患者报告结局测量指标:LupusQoL 和 FACIT-Fatigue 的内容效度。
J Patient Rep Outcomes. 2024 Sep 30;8(1):115. doi: 10.1186/s41687-024-00783-z.
3
Evolving Concepts in Treat-to-Target Strategies for Systemic Lupus Erythematosus.

本文引用的文献

1
All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013).加拿大安大略省系统性红斑狼疮患者 43 年来(1971-2013 年)的全因、病因特异性和年龄特异性标准化死亡率比。
Ann Rheum Dis. 2019 Jun;78(6):802-806. doi: 10.1136/annrheumdis-2018-214802. Epub 2019 Apr 16.
2
Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies.贝利尤单抗对系统性红斑狼疮患者报告结局的影响:临床研究综述
Patient Relat Outcome Meas. 2019 Jan 9;10:1-7. doi: 10.2147/PROM.S134326. eCollection 2019.
3
系统性红斑狼疮达标治疗策略的演变概念
Mediterr J Rheumatol. 2024 Jun 30;35(Suppl 2):328-341. doi: 10.31138/mjr.290424.eci. eCollection 2024 Jun.
4
[Epidemiological, clinical, and biochemical characteristics of patients in the LUPUS-IMMex cohort].[LUPUS-IMMex队列中患者的流行病学、临床和生化特征]
Rev Med Inst Mex Seguro Soc. 2024 Jan 8;62(1):1-6. doi: 10.5281/zenodo.10278103.
5
Vision-Related Quality of Life in Patients with Systemic Lupus Erythematosus.系统性红斑狼疮患者与视力相关的生活质量
Healthcare (Basel). 2024 Feb 24;12(5):540. doi: 10.3390/healthcare12050540.
6
Efficacy of lifestyle interventions in the management of systemic lupus erythematosus: a systematic review of the literature.生活方式干预在系统性红斑狼疮管理中的疗效:文献系统评价。
Rheumatol Int. 2024 May;44(5):765-778. doi: 10.1007/s00296-024-05548-x. Epub 2024 Mar 7.
7
Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in SLE: a cross-sectional study.肥胖症和吸烟与 SLE 患者报告的不良结局独立相关:一项横断面研究。
Rheumatol Int. 2024 May;44(5):851-861. doi: 10.1007/s00296-024-05546-z. Epub 2024 Mar 7.
8
Obesity is associated with pain and impaired mobility despite therapy in systemic lupus erythematosus.尽管进行了系统性红斑狼疮治疗,但肥胖仍与疼痛和行动不便相关。
Front Med (Lausanne). 2023 Aug 24;10:1247354. doi: 10.3389/fmed.2023.1247354. eCollection 2023.
9
Health-related quality of life and its related factors in patients with systemic lupus erythematosus in southwest Iran: a cross-sectional study.伊朗西南部系统性红斑狼疮患者的健康相关生活质量及其相关因素:一项横断面研究。
BMC Psychol. 2023 Sep 1;11(1):259. doi: 10.1186/s40359-023-01300-5.
10
Impact of Belimumab on Patient-Reported Outcomes in Systemic Lupus Erythematosus: Insights from Clinical Trials and Real-World Evidence.贝利尤单抗对系统性红斑狼疮患者报告结局的影响:来自临床试验和真实世界证据的见解
Patient Relat Outcome Meas. 2023 Jan 19;14:1-13. doi: 10.2147/PROM.S369584. eCollection 2023.
Fatigue in systemic lupus: the role of disease activity and its correlates.
系统性红斑狼疮中的疲劳:疾病活动度及其相关因素的作用
Lupus. 2019 Feb;28(2):163-173. doi: 10.1177/0961203318817826. Epub 2018 Dec 22.
4
The Impact of Belimumab and Rituximab on Health-Related Quality of Life in Patients With Systemic Lupus Erythematosus.贝利尤单抗和利妥昔单抗对系统性红斑狼疮患者健康相关生活质量的影响。
Arthritis Care Res (Hoboken). 2019 Jun;71(6):811-821. doi: 10.1002/acr.23718.
5
The impact of obesity on health-related quality of life in Spain.肥胖对西班牙健康相关生活质量的影响。
Health Qual Life Outcomes. 2017 Oct 10;15(1):197. doi: 10.1186/s12955-017-0773-y.
6
Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).疾病活动对系统性红斑狼疮患者健康相关生活质量的影响——瑞士系统性红斑狼疮队列研究(SSCS)的横断面分析
BMC Immunol. 2017 Mar 28;18(1):17. doi: 10.1186/s12865-017-0200-5.
7
Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus.吸烟和预先存在的器官损伤会降低贝利尤单抗治疗红斑狼疮的疗效。
Autoimmun Rev. 2017 Apr;16(4):343-351. doi: 10.1016/j.autrev.2017.02.005. Epub 2017 Feb 13.
8
Impact of cognitive impairment, depression, disease activity, and disease damage on quality of life in women with systemic lupus erythematosus.认知障碍、抑郁、疾病活动及疾病损伤对系统性红斑狼疮女性患者生活质量的影响
Scand J Rheumatol. 2017 Jul;46(4):273-280. doi: 10.1080/03009742.2016.1206617. Epub 2016 Oct 5.
9
Understanding remission in real-world lupus patients across five European countries.了解五个欧洲国家现实世界中狼疮患者的缓解情况。
Lupus. 2016 Apr;25(5):505-12. doi: 10.1177/0961203315619030. Epub 2015 Dec 2.
10
Determination of the minimal clinically important difference for seven measures of fatigue in Swedish patients with systemic lupus erythematosus.确定瑞典系统性红斑狼疮患者七种疲劳测量指标的最小临床重要差异。
Scand J Rheumatol. 2015 May;44(3):206-10. doi: 10.3109/03009742.2014.988173. Epub 2015 Feb 6.